CSPC PHARMACEUTICAL GROUP LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 1093 for the last semiannual is 17.65 B HKD, and it's 6.27% higher compared to the previous semiannual. The net income of H1 24 is 3.27 B HKD.